Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-13-036697
Filing Date
2013-02-04
Accepted
2013-02-04 16:12:24
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO SCHEDULE 13G d477331dsc13ga.htm SC 13G/A 38805
  Complete submission text file 0001193125-13-036697.txt   40138
Mailing Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021
Business Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021 720-940-2200
ARCA biopharma, Inc. (Subject) CIK: 0000907654 (see all company filings)

EIN.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-51477 | Film No.: 13570173
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address
Business Address
BRISTOW MICHAEL R (Filed by) CIK: 0001266125 (see all company filings)

Type: SC 13G/A